<A HREF="http://sc.ifeng.com/event.ng/Type=click&FlightID=21821&AdID=21594&TargetID=304&Segments=1,160,262,871&Targets=882,196,304,811&Values=34,46,51,81,100,110,204,228,238,263,305,583&RawValues=&Redirect=http://ad.cn.doubleclick.net/click;h=v2|3AFC|0|0|%2a|w;214677492;0-0;0;36519659;31-1|1;21717145|21735035|1;;%3fhttp://www-900.ibm.com/innovation/cn/healthcare/index.shtml?ca=apch_sp-20090511&me=banner&met=sp&re=ifeng&s_tact=chspb002&cm_mmc=apch_sp-20090511-chspb002-_-b-_-sp-_-ifeng" target="_blank"><IMG SRC="http://img.ifeng.com/tres/recommend/client/ibm2007/090512-ibm_finance-950x90.swf" WIDTH=950 HEIGHT=90 BORDER=0></A>

凤凰财经 > 港股 > 综合损益表 > 新华制药 (00719.HK)
港股代码：

00719 山东新华制药股份有限公司 - H股

综合损益表
单位: 人民币 (元) 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
营业额  2,077,753,000.00  1,865,568,000.00  1,685,367,000.00  1,712,102,000.00  1,524,409,000.00
除税前盈利/(亏损)  41,447,000.00  37,364,000.00  29,733,000.00  13,194,000.00  -52,352,000.00
税项  -5,677,000.00  400,000.00  -7,784,000.00  -13,696,000.00  -1,119,000.00
除税后盈利/(亏损)  35,770,000.00  37,764,000.00  21,949,000.00  -502,000.00  -53,471,000.00
少数股东权益  -5,706,000.00  -5,946,000.00  812,000.00  -1,731,000.00  -986,000.00
股东应占盈利/(亏损)  30,064,000.00  31,818,000.00  22,761,000.00  1,229,000.00  -52,485,000.00
股息   --   13,719,000.00   9,146,000.00   22,866,000.00   0.00
除税及股息后盈利/(亏损)  30,064,000.00  18,099,000.00  13,615,000.00  -21,637,000.00  -52,485,000.00
基本  6.60  7.00  5.00  0.30  -11.50
摊薄  --  --  --  --  --
销售成本  1,776,658,000.00  1,570,246,000.00  1,381,010,000.00  1,400,869,000.00  1,267,109,000.00
折旧   115,739,000.00   103,710,000.00   99,661,000.00   94,816,000.00   88,163,000.00
利息费用/融资成本   17,956,000.00   12,183,000.00   20,475,000.00   22,166,000.00   15,384,000.00
毛利/(亏损)  301,095,000.00  295,322,000.00  304,357,000.00  311,233,000.00  257,300,000.00
经营盈利/(亏损)  41,447,000.00  37,364,000.00  29,733,000.00  13,194,000.00  -52,352,000.00